此页面上的内容需要较新版本的 Adobe Flash Player。

获取 Adobe Flash Player

首页 > ENGLISH > Provincial Key Clinical Specialty
QCHC

Heart Center of Qingdao Women and Children’s Hospital (Qingdao Children’s Heart Center, QCHC) from May 2004, is one of the largest specialized children’s heart center of China, with 14 doctors and 40 nurses, 45 in-patient beds and 16 cardiac intensive care unit(CICU) beds. QCHC, armed with top-class equipments, such as two special operating rooms, one digital subtraction angiography machine and three echo machines, includes eight subspecialties, cardiac surgery, pediatric cardiology, thoracic surgery, critical intensive medicine, anesthesiology, cardiopulmonary bypass, transcatheter intervention and echocardiography. QCHC, the key discipline of cardiothoracic surgery of Shandong Province, has been authorized to develop postgraduate training projects by Qingdao University since 2004. 
  Every year more than 800 various congenital heart defects(CHD), over 60% of whom are complex malformations, such as severe Tetraology of Fallot, Transposition of Great Arteries, Hypoplastic Left or Right Heart Syndrome, were corrected here, with the overall successful ratio of over 95%. 80% of the surgical patients have the bodyweight lower than 10kg. The interventional cardiology includes stent implantation in branch stenosis, critical pulmonary ans aortic stenosis.
  Pioneered in transthoracic minimally invasive device closure technique, QCHC has advanced its application at home and aborad, and presented our experience in the important professional meetings such as PCCS2009, ATCSA2009, EACTS2011(Switzerland), ISMICVS2014(Boston, America), AATS2014(Toronto, Canada). The chief surgeon, Prof. QS Xing organized the completion of the Guideline of Transthoracic Minimally Invasive Device Closure of VSD. Supported by Natural Scientific Fund of China in the last ten years, QCHC has completed five important research items and published up to 100 papers including 《J Thorac Cardiovasc Surg》,《Ann Thorac Surg》, 《Eur J Cardiothorac Surg》, 《Eur Heart J》, awarded by Qingdao and Shandong provincial government.
  Cooperated with the charity organizations, QCHC has successfully operated nearly 2000 CHD patients free of charge from the families. In the last few years, QCHC has been awarded many collective honors such as National May 1st Labor Award, Qingdao Brand of Public Health Excellent Volunteer Service, and so on. Thus far, the advanced technology and correlated deeds of QCHC have been reported by national and local media more than 100 times.

The Chief Surgeon

Prof. Quansheng Xing, the chief surgeon of QCHC, is also the president of Qingdao Women and Children’s Hospital, director of Qingdao Women and children health care and fertilization planning center,the vice president of Committee of Congenital Heart Disease, Chinese Association of Cardiovascular Surgeon, doctoral supervisor and professor of Qingdao University. He also holds his posts in the editorial committees of several core journals, such as《Chinese Journal of Experimental Surgery》,《Journal of International Cardiovascular Disease》. He has completed four important research items supported by Natural Scientific Fund of China in the last ten years with inspiring results, and published more than 50 papers, including some papers in 《J Thorac Cardiovasc Surg》,《Ann Thorac Surg》,《Eur J Cardiothorac Surg》,《Eur Heart J》.
  Up to now, Dr. Xing has successfully performed nearly 6000 various cardiac operations. Among the survived patients, a preterm neonate of 1.4 kg who suffered from interruption of aortic arch (IAA) with intra-cardiac anomalies, and the youngest patient, weighted only 2.5 kg, received successful correction of TGA 12 hours after birth. Dr. Xing is so famous that he has been titled as “The First Scapel of Children’s Heart Surgery in Qingdao” by colleagues, patients and their families.
  For his excellence in scientific research and clinical treatment, Dr. Xing was praised by Health Department of China and local governments. Especially, in 2005, he was awarded Chinese Doctor Prize, the highest honor in the medical field of China.
  Dr. Xing is the pioneer of transthoracic minimally invasive device closure technique with several state-authorized patents. He has been invited to present his experience in this field on PCCS2009(Cairns, Australia), ATCSA2009(Seoul, Korea),EACTS2011(Switzerland), ISMICVS2014(Boston, America), AATS2014(Toronto, Canada). Guideline of Transthoracic Minimally Invasive Device Closure of Ventricular Septal Defect was completed by Xing and colleagues in 2011, and has now become the gold standard of this procedure. The book of Transthoracic Minimally Invasive Device Closure of Congenital Heart Defects by Xing, as the first textbook in this field, was published in 2014.

下一页

版权所有 新万博体育 地址:青岛市市北区同福路6号 电话:0532-68661155 传真:0532-68661111

鲁ICP备08109525号-1 技术支持:365健康在线(青岛信息港健康频道)